Alvotech ALVO 深 沪
等待开盘 05-13 09:30:00 美东时间
3.55
-0.040
-1.11%
华盛通- 最 高3.5929
- 今 开3.59
- 成交量 37.74万股
- 最 低 3.375
- 昨 收 3.59
- 总市值 11.08亿
- 52周最高 11.85
- 市盈率 静 37.06
- 换手率 0.12%
- 52周最低 3.03
- 委 比 -79.54%
- 总股本 3.12亿
- 历史最高 18.00
- 量 比 0.76
- 振 幅 6.07%
- 历史最低 3.03
- 每 手 1
- 风险率 2.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alvotech shares rise as FDA completes Reykjavik facility inspection
Alvotech (ALVO) Monday said that the U.S. Food and Drug Administration (FDA) has completed a routine cGMP surveillance inspection of the company’s manufacturing facility in Reykjavik, Iceland, sending...
05-11 19:10
Alvotech says FDA completes inspection of Reykjavik manufacturing plant
Alvotech says FDA completes inspection of Reykjavik manufacturing plant FDA completed routine inspection of Alvotech manufacturing site in Reykjavik on May 8, issuing inspectional observations that Alvotech expects to address quickly without major remediation. Inspection outcome clears path to resub
05-11 16:30
Alvotech announces completion of FDA surveillance inspection at Reykjavik facility
Alvotech announced that the FDA completed a routine cGMP inspection of its Reykjavik manufacturing facility, issuing a Form 483 on May 8, 2026. The company believes the observations can be quickly addressed and does not raise substantial issues. Alvotech is well-positioned to resubmit relevant BLAs this quarter and continues to expect FDA approval in 2026. The inspection outcome highlights the site's strong cGMP fundamentals and improvements impl...
05-11 08:30
Alvotech shares are trading higher after the company reported better-than-expected Q1 sales results.
Alvotech shares are trading higher after the company reported better-than-expec...
05-07 05:07
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Agilon Health (NYSE:AGL) stock increased by 22.1% to $34.0 during Wedn...
05-07 05:03
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Alvotech Q1 Sales $105.900M Miss $140.847M Estimate
Alvotech (NASDAQ:ALVO) reported quarterly sales of $105.900 million which missed the analyst consensus estimate of $140.847 million by 24.81 percent. This is a 20.26 percent decrease over sales of $132.800 million the
05-07 04:34
Alvotech Announces General Counsel Transition After Six-Year Tenure
Alvotech ( ($ALVO) ) just unveiled an update. Alvotech, a global biotech group ...
05-04 20:57
Alvotech updates financial calendar ahead of quarterly results webcast
Alvotech updates financial calendar ahead of quarterly results webcast Alvotech schedules Q1 2026 financial results release for May 6, 2026, following U.S. market close. Management plans webcast with live Q&A for May 7, 2026 at 08:00 EST. Investor presentation materials to post ahead of webcast at h
04-24 20:30
Pelthos Therapeutics names John M. Gay as CFO
Pelthos Therapeutics (PTHS) announced on Friday the appointment of John M. Gay as CFO, effective April 10, 2026, succeeding Francis Knuettel II. Gay brings over 25 years of public company finance and ...
04-11 05:11
